BETHLEHEM, Pa., July 26, 2012 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (Nasdaq:OSUR), the market leader in oral fluid diagnostics, today announced its support of numerous rapid hepatitis C (HCV) testing initiatives for World Hepatitis Day, taking place on July 28, 2012. These testing initiatives will occur in various cities in the U.S., including Chicago, New York, and Washington, D.C., and in several foreign countries, to help encourage thousands of people to get tested for hepatitis C. OraSure manufactures the OraQuick® Rapid HCV test, the first and only rapid HCV test approved by the U.S. Food and Drug Administration (FDA).
